Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
33.83
-1.08 (-3.09%)
Aug 17, 2026, 11:07 AM EDT - Market open
Tectonic Therapeutic Employees
Tectonic Therapeutic had 60 employees as of December 31, 2025. The number of employees increased by 9 or 17.65% compared to the previous year.
Employees
60
Change (1Y)
9
Growth (1Y)
17.65%
Revenue / Employee
n/a
Profits / Employee
-$1,429,783
Market Cap
661.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 60 | 9 | 17.65% |
| Dec 31, 2024 | 51 | 7 | 15.91% |
| Mar 31, 2024 | 45 | - | - |
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| 4D Molecular Therapeutics | 196 |
| Allogene Therapeutics | 152 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| Assembly Biosciences | 73 |
TECX News
- 10 days ago - Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 11 days ago - Tectonic Therapeutic Quarterly report: Q2 2026 - Filings
- 11 days ago - Tectonic Therapeutic Earnings release: Q2 2026 - Filings
- 16 days ago - Tectonic Therapeutic Slides: Investor presentation - Filings
- 2 months ago - Tectonic Therapeutic completes enrollment for APEX trial - TheFly
- 2 months ago - Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Transcript: AGM 2026 - Transcripts
- 2 months ago - Tectonic Therapeutic upgraded to Strong Buy from Outperform at Raymond James - TheFly